SELECT MEDICAL HOLDINGS CORP (SEM) Stock Fundamental Analysis

NYSE:SEM • US81619Q1058

16.28 USD
+0.05 (+0.31%)
Last: Feb 12, 2026, 03:58 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, SEM scores 4 out of 10 in our fundamental rating. SEM was compared to 102 industry peers in the Health Care Providers & Services industry. While SEM is still in line with the averages on profitability rating, there are concerns on its financial health. SEM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SEM had positive earnings in the past year.
  • SEM had a positive operating cash flow in the past year.
  • Each year in the past 5 years SEM has been profitable.
  • SEM had a positive operating cash flow in each of the past 5 years.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • With a decent Return On Assets value of 3.72%, SEM is doing good in the industry, outperforming 68.63% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 12.53%, SEM is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.34%, SEM is in line with its industry, outperforming 50.98% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SEM is significantly below the industry average of 9.04%.
  • The 3 year average ROIC (3.10%) for SEM is below the current ROIC(4.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROIC 4.34%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • SEM has a better Profit Margin (4.08%) than 75.49% of its industry peers.
  • In the last couple of years the Profit Margin of SEM has grown nicely.
  • SEM has a Operating Margin of 5.17%. This is in the better half of the industry: SEM outperforms 64.71% of its industry peers.
  • In the last couple of years the Operating Margin of SEM has declined.
  • SEM has a Gross Margin of 12.22%. This is in the lower half of the industry: SEM underperforms 70.59% of its industry peers.
  • SEM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SEM is destroying value.
  • The number of shares outstanding for SEM has been increased compared to 1 year ago.
  • The number of shares outstanding for SEM has been reduced compared to 5 years ago.
  • SEM has a better debt/assets ratio than last year.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.59, we must say that SEM is in the distress zone and has some risk of bankruptcy.
  • SEM's Altman-Z score of 1.59 is in line compared to the rest of the industry. SEM outperforms 41.18% of its industry peers.
  • The Debt to FCF ratio of SEM is 10.18, which is on the high side as it means it would take SEM, 10.18 years of fcf income to pay off all of its debts.
  • SEM has a Debt to FCF ratio of 10.18. This is comparable to the rest of the industry: SEM outperforms 45.10% of its industry peers.
  • SEM has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
  • SEM has a Debt to Equity ratio of 1.03. This is in the lower half of the industry: SEM underperforms 62.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Altman-Z 1.59
ROIC/WACC0.44
WACC9.94%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • SEM has a Current Ratio of 1.09. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.09, SEM is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.09 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a Quick ratio of 1.09. This is comparable to the rest of the industry: SEM outperforms 41.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • SEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.81%.
  • The Earnings Per Share has been growing slightly by 5.88% on average over the past years.
  • SEM shows a small growth in Revenue. In the last year, the Revenue has grown by 7.48%.
  • The Revenue has been decreasing by -1.00% on average over the past years.
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.83% on average over the next years.
  • The Revenue is expected to decrease by -2.85% on average over the next years.
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • SEM is valuated rather expensively with a Price/Earnings ratio of 18.93.
  • Based on the Price/Earnings ratio, SEM is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
  • SEM is valuated rather cheaply when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 12.30, which indicates a correct valuation of SEM.
  • 85.29% of the companies in the same industry are more expensive than SEM, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. SEM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.93
Fwd PE 12.3
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SEM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SEM is cheaper than 76.47% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, SEM is valued cheaply inside the industry as 81.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.58
EV/EBITDA 8.9
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • SEM has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as SEM's earnings are expected to decrease with -2.53% in the coming years.
PEG (NY)N/A
PEG (5Y)3.22
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • SEM has a Yearly Dividend Yield of 1.62%.
  • SEM's Dividend Yield is rather good when compared to the industry average which is at 0.48. SEM pays more dividend than 89.22% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, SEM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

  • SEM has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 18.80% of the earnings are spent on dividend by SEM. This is a low number and sustainable payout ratio.
DP18.8%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (2/12/2026, 3:58:08 PM)

16.28

+0.05 (+0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners82.91%
Inst Owner Change-2.73%
Ins Owners11.06%
Ins Owner Change0.26%
Market Cap2.02B
Revenue(TTM)5.19B
Net Income(TTM)211.72M
Analysts77.78
Price Target18.53 (13.82%)
Short Float %4.23%
Short Ratio4.71
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP18.8%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.01%
Min EPS beat(2)30.21%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)-20.63%
Min EPS beat(4)-158.51%
Max EPS beat(4)49.82%
EPS beat(8)4
Avg EPS beat(8)-7.1%
EPS beat(12)7
Avg EPS beat(12)-2.62%
EPS beat(16)9
Avg EPS beat(16)-3.49%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-3.63%
Min Revenue beat(4)-11.07%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.53%
Revenue beat(12)7
Avg Revenue beat(12)-0.91%
Revenue beat(16)10
Avg Revenue beat(16)5.68%
PT rev (1m)0%
PT rev (3m)0.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)3.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 18.93
Fwd PE 12.3
P/S 0.39
P/FCF 11.58
P/OCF 4.95
P/B 1.19
P/tB N/A
EV/EBITDA 8.9
EPS(TTM)0.86
EY5.28%
EPS(NY)1.32
Fwd EY8.13%
FCF(TTM)1.41
FCFY8.63%
OCF(TTM)3.29
OCFY20.22%
SpS41.89
BVpS13.64
TBVpS-6.02
PEG (NY)N/A
PEG (5Y)3.22
Graham Number16.25
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROCE 5.65%
ROIC 4.34%
ROICexc 4.39%
ROICexgc 9.14%
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
FCFM 3.35%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
ROICexc(3y)3.14%
ROICexc(5y)4.99%
ROICexgc(3y)6.3%
ROICexgc(5y)12.6%
ROCE(3y)4.06%
ROCE(5y)6.32%
ROICexgc growth 3Y-27.06%
ROICexgc growth 5Y-9.65%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-5.51%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
F-Score5
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Debt/EBITDA 4.17
Cap/Depr 155.87%
Cap/Sales 4.5%
Interest Coverage 2.17
Cash Conversion 97.47%
Profit Quality 82.19%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.59
F-Score5
WACC9.94%
ROIC/WACC0.44
Cap/Depr(3y)103.75%
Cap/Depr(5y)94.3%
Cap/Sales(3y)4.39%
Cap/Sales(5y)3.74%
Profit Quality(3y)115.02%
Profit Quality(5y)150.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A
EBIT growth 1Y0.4%
EBIT growth 3Y-27.83%
EBIT growth 5Y-10.68%
EBIT Next Year-15.98%
EBIT Next 3Y-1.14%
EBIT Next 5YN/A
FCF growth 1Y-9.04%
FCF growth 3Y10.24%
FCF growth 5Y0.52%
OCF growth 1Y-1.83%
OCF growth 3Y8.88%
OCF growth 5Y3.07%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 6 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 18.93 and the Price/Book (PB) ratio is 1.19.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.